Dr. Nathan Chen leaves OBI Pharma; Accepts New Role on Company’s Medical Advisory Board

OBI Pharma today announced that Dr. Nathan Chen has resigned his post as Chief Medical Officer for personal reasons, effective from August 10, 2016. Dr. Chen continues to be deeply committed to the success of OBI Pharma and will join the company’s Medical Advisory Board on August 11, 2016. During his time at OBI Pharma, […]

HOMEWhat’s NewNewsDr. Nathan Chen leaves OBI Pharma; Accepts New Role on Company’s Medical Advisory Board

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2016.Jul.27

Quick Takes on Promising New Approaches to Treating Breast Cancer

2016.Sep.03

Michael Chang: “the U.S. Department of Justice Had Already Proven My Innocence”